Sogephar SRL
1.4 FTEThe score of Sogephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +32 % Total assets +33 % Headcount (avg FTE) +40 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sogephar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 23,219 € | ||||
| Equity | 233,192 € | ||||
| Cash | 148,097 € | ||||
| EBITDA | 45,516 € | ||||
| Total assets | 337,204 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 May 2026
- Year ended 31 Dec 2024filed on 08 May 2025
- Year ended 31 Dec 2023filed on 10 May 2024
- Year ended 31 Dec 2022filed on 11 May 2023
- Year ended 31 Dec 2021filed on 16 May 2022
Sogephar's financial analysis
- Solvency69.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sogephar
Sogephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.090.923
- VAT number
- BE0403090923
- Peppol
- Registered · 0208:0403090923 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Oct 1949
- Registered office
- 1050 Ixelles
- Size
- Micro · 1.4 FTE
- Latest accounts
- 2025 · filed on 28 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sogephar (SRL) has been based in Ixelles since 1949, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 23,219 € and equity of 233,192 €; its revenue is not published. With 1.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 69.2%, above the median of its sector (37.8%).
Companies similar to Sogephar
Companies in the same business, of comparable size and area, outside its group.
- Les Pharmacies Réunies Retail sale of pharmaceutical products Frameries · balance sheet 389,988 €
- QualiThink Business and other management consultancy activities Chastre · balance sheet 523,033 €
- Blauwblomme Retail sale of pharmaceutical products Kortrijk · balance sheet 559,420 €
- Pharmacie Baudoux M.C. Retail sale of pharmaceutical products Gerpinnes · balance sheet 313,886 €
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
- Pharm-OZ Retail sale of pharmaceutical products Charleroi · balance sheet 681,585 €
- Sirrah Retail sale of pharmaceutical products Tournai · balance sheet 84,897 €
- Apotheek Kestelyn Retail sale of pharmaceutical products Ypres · balance sheet €1.86m
Frequently asked questions about Sogephar
What is the revenue of Sogephar?
Sogephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sogephar?
In Belgium, the VAT number is the company number prefixed with BE: BE0403090923 for Sogephar, if the company is VAT-registered. Its company number (CBE) is 0403.090.923.
Where is the registered office of Sogephar?
According to the CBE register, the registered office of Sogephar is in 1050 Ixelles.
What is the equity of Sogephar?
At the close of the 2025 financial year, the equity of Sogephar amounts to 233,192 €, a solvency of 69.2% of total assets.
How many people work at Sogephar?
1.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sogephar?
The register lists 1 active mandates at Sogephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sogephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →